UNIVERSITäTSKLINIKUM TüBINGEN - DE 

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 2.728.340 0 1
2016 0 1.674.240 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ACADEMISCH ZIEKENHUIS GRONINGEN1
ADAPTVAC APS1
CHECKPOINTS1
CHR HANSEN1
COPAN1
EDINBURGH MOLECULAR IMAGING1
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON1
EXPRES2ION BIOTECHNOLOGIES APS1
GILEAD SCIENCES INC1
INSTITUTE OF PHOTONIC TECHNOLOGY LEIBNIZ1
INTEGRATED DISEASE MANAGEMENT CORPORATION BV1
JULIUSMAXIMILIANS UNIVERSITAET WUERZBURG1
KAROLINSKA INSTITUTE1
KING'S COLLEGE LONDON1
LABHELP INTERNATIONAL BV1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
MAD MULTIMEDIA1
MSD BV1
NATIONAL ENTEROVIRUS REFERENCE CENTER1
NUTRICIA RESEARCH BV1
QUEEN MARGARET UNIVERSITY EDINBURGH1
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM1
STICHTING RADBOUD UNIVERSITEIT1
STICHTING WETSUS EUROPEAN CENTRE OF EXCELLENCE FOR SUSTAINABLE WATER TECHNOLOGY1
THE UNIVERSITY OF ADELAIDE1
THE UNIVERSITY OF LIVERPOOL1
THE UNIVERSITY OF TUEBINGEN1
THERMOFISHER SCIENTIFIC1
UCBPHARMA1
UNIVERSITY CHEST CLINIC LASI1
UNIVERSITY OF BERGEN1
UNIVERSITY OF COPENHAGEN1
VISMEDERI1
WAGENINGEN UNIVERSITY1

Constancy:

Total number of partners: 34
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 34
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2020-04-01Prevention of SARS-CoV-2 infection through development and clinical testing of a novel Virus Like Particle (VLP) vaccine Prevent-nCoVparticipant2.728.3409
2016-09-01Protecting patients with enhanced susceptibility to infections PRONKJEWAILparticipant1.674.24027